NCT07486713 2026-03-20
Olutasidenib DDI Study in Patients With IDH1 Mutation Positive Malignancies
Rigel Pharmaceuticals
Phase 4 Recruiting
Clinical Trials
8 trialsNCT06417606 2024-05-22
Lenvatinib and Adebrelimab Combined With GEMOX in the Perioperative Treatment of Potentially Resectable Intrahepatic Cholangiocarcinoma
Tongji Hospital
Phase 4 Not yet recruiting
NCT05124002 2024-03-04
Recombinant Human Adenovirus Type 5 Plus HAIC of FOLFOX for Intrahepatic Cholangiocarcinoma
Beijing Tsinghua Chang Gung Hospital
Phase 4 Unknown
NCT02174575 2023-05-03
Anesthetic Agents and Acute Kidney Injury After Liver Resection Surgery
Tokyo Medical and Dental University
Phase 4 Withdrawn
NCT01642875 2016-11-23
Early Oral Versus Enteral Nutrition After Pancreatoduodenectomy
Medical University of Warsaw
Phase 4 Unknown
NCT02027311 2015-06-29
Etomidate vs. Midazolam for Sedation During ERCP
Cheju Halla General Hospital
Phase 4 Completed
NCT00797121 2008-11-25
Preoperative Biliary Drainage for Resectable Hilar Cholangiocarcinoma
Sun Yat-sen University
Phase 4 Unknown
NCT00168987 2008-05-09
Influence of an Oral Nutritional Supplement Rich in Omega-3 Fatty Acids on Functional State and Quality of Life in Malnourished Patients With Gastroenterological Tumors
Charite University, Berlin, Germany
Phase 4 Completed